Contact us
Our Products

Preeclampsia Screening Test

  • You are in Preeclampsia Screening Test

Preeclampsia Screening Test

An innovative, rapid, non-invasive, point-of-care solution for screening of preeclampsia. This test can predict development of preeclampsia in the upcoming weeks of gestation based on the levels of a preeclampsia specific biomarker.
Innovatively developed

Preeclampsia Screening Test

WHAT

Detects a protein from a drop of sample in 15-20 minutes

WHEN

Suspected preeclampsia during any stages of gestation

WHERE

Path labs, Hospitals, IVF chains, Primary Health Care Centres

WHO CAN PERFORM THE TEST

Path Lab Technicians, Doctors, Nurses, Trained ASHA Workers
Preeclampsia Screening Test

Easy to Perform, Easier to understand

Our Test is available at low cost, is rapid (results seen in less than 20 mins), can be used for early detection (before 16th week of gestation) of preeclampsia, is a point-of-care test (no instruments required), is usable in low resource settings, can be operated by a minimally trained person, and can enable surveillance and monitoring of high-risk pregnancies.
Need for a Screening Test

Check Out Some Data Below

Early diagnosis and timely intervention can lead to a healthier pregnancy
of pregnancy related complications
2- %
maternal deaths yearly worldwide
+
fetal deaths worldwide
+ 0
annual rise in preeclampsia globally
0 %
Preeclampsia Screening Test

A Solution to the Unmet Need

Until recently, pregnant women were diagnosed for preeclampsia only after they showed elevated blood pressure and protein in the urine. As preeclampsia can strike quickly, potentially causing severe and immediate complications (such as seizures and organ failure that threaten both the health of the baby and mother) unless the pregnancy is induced, early and point of care diagnostic tests are needed. Currently, there are no tests available for screening pregnant women to determine the risk of preeclampsia development. We have developed a screening test for all pregnant women which can predict preeclampsia development in the upcoming weeks of gestation based on the levels of a preeclampsia specific biomarker.
A CareFree Pregnancy !

Know the risks for you and your baby

Discovering and Developing Solutions for Women’s Health and Well-Being During Pregnancy.
Facebook Instagram Linkedin
Explore
Contact

Sign up for newsletter

©2024. Intignus Biotech. All rights reserved.

Website Developed by Eternitty.